Traversa Sergio
Relmada Therapeutics, Inc. · Chief Executive Officer
Traversa Sergio is listed in filings as Chief Executive Officer at Relmada Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including purchase activity. Recent filings connect the profile to Relmada Therapeutics, Inc. (RLMD). The current snapshot covers public activity from Sep 11, 2024 to Dec 16, 2025. Reported amounts are shown as $150.6K to $153.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $151k55.6k shares | BuySep 9, 2024 | $2.71 | $5.24 | |
| $91k33k shares | BuySep 10, 2024 | $2.75 | $5.24 | |
| $154k51.4k shares | BuySep 11, 2024 | $2.99 | $5.24 | |
| $77k172.3k shares | BuyMay 16, 2025 | $0.4496 | $5.24 | |
| $15k30k shares | BuyMay 19, 2025 | $0.4998 | $5.24 | |
| $82k147.7k shares | BuyMay 20, 2025 | $0.5569 | $5.24 | |
| $50k80.5k shares | BuyAug 26, 2025 | $0.62 | $5.24 | |
| $87k129.5k shares | BuyAug 27, 2025 | $0.67 | $5.24 | |
| $41k56k shares | BuyAug 28, 2025 | $0.74 | $5.24 | |
| $600k272.5k shares | BuyNov 5, 2025 | $2.20 | $5.24 |